Search research articles
Contact Us
Filters
Showing results (801-810 of 949) with videos related to
Page
of 95
Sort By:
Neurology. Clinical Practice
|
August 26, 2024
Utilization, Workflow, and Outcomes of Endovascular Thrombectomy in Patients With vs Without Premorbid Disability in a National Registry
Aravind Ganesh, Ondrej Volny, Ingrid Kovacova, et al.
Lancet (London, England)
|
March 17, 2023
Bayesian reconstruction of household transmissions to infer the serial interval of COVID-19 by variants of concern: analysis from a prospective community cohort study (Virus Watch)
Cyril Geismar, Vincent Nguyen, Ellen Fragaszy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma
J P Ginsberg, E de Alava, M Ladanyi, et al.
Journal of Innate Immunity
|
February 5, 2016
Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational Medicine
Peter Valent, Bernd Groner, Udo Schumacher, et al.
Oncogenesis
|
January 9, 2021
YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells
Lisa Bierbaumer, Anna M Katschnig, Branka Radic-Sarikas, et al.
European Journal of Medicinal Chemistry
|
December 24, 2025
Novel pyrimidine derivatives as promising antimycobacterial agents
Martin Kufa, Vladimir Finger, Ondrej Kovar, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 18, 1999
Potent and orally bioavailable noncysteine-containing inhibitors of protein farnesyltransferase
D J Augeri, D Janowick, D Kalvin, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 7, 2010
Substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as multi-targeted inhibitors of insulin-like growth factor-1 receptor (IGF1R) and members of ErbB-family receptor kinases
Gary T Wang, Robert A Mantei, Robert D Hubbard, et al.
International Journal of Cancer
|
October 5, 2006
Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics
Zehan Chen, Zhan Xiao, Wen-Zhen Gu, et al.
American Journal of Medical Genetics. Part A
|
April 11, 2020
Phenotypic expansion of Bosch-Boonstra-Schaaf optic atrophy syndrome and further evidence for genotype-phenotype correlations
Megan E Rech, John M McCarthy, Chun-An Chen, et al.
Page
of 95
Search research articles
Search
Showing results (801-810 of 949) with videos related to
Sort By:
Page
of 95
Neurology. Clinical Practice
|
August 26, 2024
Utilization, Workflow, and Outcomes of Endovascular Thrombectomy in Patients With vs Without Premorbid Disability in a National Registry
Aravind Ganesh, Ondrej Volny, Ingrid Kovacova, et al.
Lancet (London, England)
|
March 17, 2023
Bayesian reconstruction of household transmissions to infer the serial interval of COVID-19 by variants of concern: analysis from a prospective community cohort study (Virus Watch)
Cyril Geismar, Vincent Nguyen, Ellen Fragaszy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma
J P Ginsberg, E de Alava, M Ladanyi, et al.
Journal of Innate Immunity
|
February 5, 2016
Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational Medicine
Peter Valent, Bernd Groner, Udo Schumacher, et al.
Oncogenesis
|
January 9, 2021
YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells
Lisa Bierbaumer, Anna M Katschnig, Branka Radic-Sarikas, et al.
European Journal of Medicinal Chemistry
|
December 24, 2025
Novel pyrimidine derivatives as promising antimycobacterial agents
Martin Kufa, Vladimir Finger, Ondrej Kovar, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 18, 1999
Potent and orally bioavailable noncysteine-containing inhibitors of protein farnesyltransferase
D J Augeri, D Janowick, D Kalvin, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 7, 2010
Substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as multi-targeted inhibitors of insulin-like growth factor-1 receptor (IGF1R) and members of ErbB-family receptor kinases
Gary T Wang, Robert A Mantei, Robert D Hubbard, et al.
International Journal of Cancer
|
October 5, 2006
Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics
Zehan Chen, Zhan Xiao, Wen-Zhen Gu, et al.
American Journal of Medical Genetics. Part A
|
April 11, 2020
Phenotypic expansion of Bosch-Boonstra-Schaaf optic atrophy syndrome and further evidence for genotype-phenotype correlations
Megan E Rech, John M McCarthy, Chun-An Chen, et al.
Page
of 95